ARKG vs. MSTZ

Last updated Jul 17, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and MSTZ (T-REX 2X Inverse MSTR Daily Target ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while MSTZ is a Inverse Equities fund actively managed by REX. Both are actively managed. Over the past year, ARKG returned 61.13% vs 299.04% for MSTZ. At a correlation of -0.39, they often move in opposite directions. ARKG charges 0.75%/yr vs 1.05%/yr for MSTZ.

Performance

ARKG vs. MSTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and T-REX 2X Inverse MSTR Daily Target ETF (MSTZ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARKG achieves a 38.38% return, which is significantly higher than MSTZ's -27.52% return.

ARKG

• 1D: -2.74%
• 1M: 14.94%
• 6M: 25.05%
• YTD: 38.38%
• 1Y: 61.13%
• 3Y*: 2.52%
• 5Y*: -13.41%
• 10Y*: 9.02%

MSTZ

• 1D: 6.51%
• 1M: 38.88%
• 6M: -2.59%
• YTD: -27.52%
• 1Y: 299.04%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. MSTZ - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ARKG ARK Genomic Revolution Multi-Sector ETF	38.38%	23.04%	-10.44%
MSTZ T-REX 2X Inverse MSTR Daily Target ETF	-27.52%	-38.95%	-94.43%

Correlation

The correlation between ARKG and MSTZ is -0.38, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.38
Correlation (All Time) Calculated using the full available price history since Sep 18, 2024	-0.39

Return for Risk

ARKG vs. MSTZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG

ARKG Risk / Return Rank: 49
ARKG Sharpe Ratio Rank: 51
ARKG Sortino Ratio Rank: 54
ARKG Omega Ratio Rank: 45
ARKG Calmar Ratio Rank: 55
ARKG Martin Ratio Rank: 41

MSTZ

MSTZ Risk / Return Rank: 70
MSTZ Sharpe Ratio Rank: 80
MSTZ Sortino Ratio Rank: 69
MSTZ Omega Ratio Rank: 69
MSTZ Calmar Ratio Rank: 83
MSTZ Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. MSTZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and T-REX 2X Inverse MSTR Daily Target ETF (MSTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARKG	MSTZ	Difference
Sharpe ratio: Return per unit of total volatility	1.43	2.03	-0.60
Sortino ratio: Return per unit of downside risk	2.13	2.49	-0.36
Omega ratio: Gain probability vs. loss probability	1.24	1.33	-0.08
Calmar ratio: Return relative to maximum drawdown	2.23	3.55	-1.32
Martin ratio: Return relative to average drawdown	5.32	6.84	-1.53

ARKG vs. MSTZ - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.43, which is comparable to the MSTZ Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of ARKG and MSTZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ARKG vs. MSTZ - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, smaller than the maximum MSTZ drawdown of -99.38%. Use the drawdown chart below to compare losses from any high point for ARKG and MSTZ.

Drawdown Indicators

	ARKG	MSTZ	Difference
Max Drawdown Largest peak-to-trough decline	-83.59%	-99.38%	+15.79%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-84.89%	+57.38%
Max Drawdown (3Y) Largest decline over 3 years	-51.96%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-79.26%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-83.59%	—	—
Current Drawdown Current decline from peak	-64.13%	-97.53%	+33.40%
Average Drawdown Average peak-to-trough decline	-36.16%	-94.55%	+58.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.54%	43.95%	-32.41%

Volatility

ARKG vs. MSTZ - Volatility Comparison

The current volatility for ARK Genomic Revolution Multi-Sector ETF (ARKG) is 12.43%, while T-REX 2X Inverse MSTR Daily Target ETF (MSTZ) has a volatility of 55.03%. This indicates that ARKG experiences smaller price fluctuations and is considered to be less risky than MSTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARKG	MSTZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.43%	55.03%	-42.60%
Volatility (6M) Calculated over the trailing 6-month period	31.47%	134.45%	-102.98%
Volatility (1Y) Calculated over the trailing 1-year period	42.93%	148.58%	-105.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.12%	170.73%	-124.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.39%	170.73%	-129.34%

ARKG vs. MSTZ - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is lower than MSTZ's 1.05% expense ratio.

Dividends

ARKG vs. MSTZ - Dividend Comparison

Neither ARKG nor MSTZ has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
MSTZ T-REX 2X Inverse MSTR Daily Target ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both ARKG and MSTZ in my portfolio?

ARKG and MSTZ have a correlation of -0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARKG or MSTZ?

MSTZ has higher volatility (55.03%) compared to ARKG (12.43%). In terms of maximum drawdown, ARKG dropped -83.59% vs MSTZ's -99.38%.

Which ETF is better, ARKG or MSTZ?

On 1-year performance, MSTZ leads with 299.04% vs 61.13% for ARKG. On fees, ARKG is cheaper at 0.75% per year. On volatility, ARKG has been the lower-risk option at 12.43%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ARKG or MSTZ?

Over the 1-year period, MSTZ has performed better with a 299.04% return vs 61.13%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ARKG or MSTZ?

ARKG is cheaper with a 0.75% expense ratio, compared with 1.05% for MSTZ.

Which ETF pays a higher dividend yield, ARKG or MSTZ?

ARKG and MSTZ have nearly identical dividend yields, around 0.00%.

What is the main difference between ARKG and MSTZ?

ARKG is categorized as Health & Biotech Equities, while MSTZ is Inverse Equities. They also come from different issuers: ARK and REX. Their fees differ too: 0.75% for ARKG and 1.05% for MSTZ.

Which has better risk-adjusted returns?

MSTZ currently has the higher Sharpe Ratio (2.03 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.